Browse the evidence

Bariatric surgery significantly improves glycemic control (HbA1c reduction) in patients with metabolic syndrome, with effects sustained over 5 years.

For patients with metabolic syndrome and Type 2 Diabetes, bariatric surgery offers significant and sustained improvements in blood sugar control, often superior to medical management alone.

Bariatric surgery significantly improves blood pressure and lipid profiles in patients with and without metabolic syndrome.

Bariatric surgery leads to significant and sustained improvements in blood pressure and lipid profiles, reducing cardiovascular risk.

Time-restricted eating (TRE) does not significantly change systolic or diastolic blood pressure in adults.

Do not expect TRE to lower blood pressure significantly on its own. If you have hypertension, continue standard medical management.

Intermittent fasting (time-restricted feeding or alternate-day fasting) is not superior to continuous energy restriction for weight loss and may have limited long-term data.

Intermittent fasting (like time-restricted feeding) can help you lose weight, but it is not necessarily better than simply eating fewer calories every day. There is not enough long-term data to recommend it as a superior long-term strategy. Choose the method that fits your lifestyle best.

Dietary polyphenols exert protective effects against neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) and aging by scavenging free radicals, inhibiting lipid peroxidation, and modulating cellular signaling pathways.

Incorporate polyphenol-rich foods like green tea (EGCG), berries, and red wine (resveratrol) into your daily diet as part of a long-term strategy to support brain health. While not a cure, these foods may help mitigate oxidative stress associated with aging and neurodegenerative risks.

Activation of SIRT1, SIRT3, and SIRT6 improves glucose metabolism and insulin sensitivity through mechanisms involving AMPK activation, NF-kB inhibition, and regulation of transcription factors like FoxO1 and PGC1α.

While specific SIRT-activating supplements are marketed, the most reliable way to support SIRT activity and metabolic health is through exercise and maintaining metabolic balance. The paper highlights that exercise improves SIRT6-mediated insulin signaling and that SIRT1 activation via AMPK helps glucose tolerance. Focus on consistent physical activity and metabolic health rather than unproven supplements.

SIRTs (particularly SIRT1, SIRT2, SIRT6, and SIRT7) exert anti-inflammatory effects by inhibiting the NF-kB pathway and reducing pro-inflammatory cytokines like TNF-alpha and IL-6.

Chronic inflammation is a risk factor for many diseases. SIRTs help regulate this process. While specific SIRT activators are not yet standard therapy, lifestyle factors that support SIRT activity (like exercise) may help manage inflammatory markers naturally.

Small molecule-based therapies and reprogramming strategies can ameliorate or reverse aging-related conditions by manipulating epigenetic mechanisms.

Epigenetic rejuvenation therapies are being developed. Consult a healthcare provider for emerging treatments.

Targeting mitochondrial dysfunction through dietary supplements (e.g., NAD+ precursors, antioxidants) and pharmacological agents shows promise in preclinical models but lacks robust clinical translation due to issues with stability and efficacy.

While specific mitochondrial supplements and drugs are being researched, current clinical evidence is limited. The most accessible way to support mitochondrial health remains regular physical activity, which promotes mitochondrial biogenesis and function, alongside a balanced diet that provides necessary nutrients for mitochondrial function.

Mitochondrial transplantation, involving the transfer of healthy mitochondria to damaged cells, is a promising preclinical therapy for various diseases but faces challenges in clinical translation due to unstable vitality and transient effects.

Mitochondrial transplantation is an experimental therapy currently limited to research settings and specific clinical trials. It is not a standard treatment. Patients interested in this therapy should consult with their healthcare provider about available clinical trials.

Wearable activity trackers have small or non-significant effects on physiological markers (blood pressure, cholesterol, glycosylated haemoglobin) and psychosocial outcomes (quality of life, pain).

While using a wearable activity tracker will likely increase your physical activity and help with weight loss, do not expect it to significantly lower your blood pressure, cholesterol, or blood sugar on its own. Similarly, improvements in quality of life or pain reduction are not guaranteed. The primary benefit is increased movement.

Routine screening of serum 25(OH)D levels is not recommended for any population (children, adults, pregnant, obese, dark complexion) in the absence of established clinical indications.

Do not get your vitamin D levels tested unless you have a specific medical condition like hypocalcemia. The guideline states that no specific blood level has been proven to prevent disease, so testing will not change your advice: just take the standard recommended dose.

Sirtuins (SIRTs) are potential therapeutic targets for NAFLD treatment, with SIRT1 playing a key role in regulating lipid metabolism and autophagy.

Sirtuins are being studied as potential drug targets for NAFLD, but no specific sirtuin-activating supplements or drugs are currently recommended for treatment.

Quercetin acts as a SIRT1 activator to mitigate aging-related diseases, including neurodegenerative disorders, by regulating oxidative stress, inflammation, and mitochondrial function.

Quercetin is a natural flavonoid found in foods like onions and grapes that may help protect against age-related brain and body decline by activating the SIRT1 protein. This activation helps reduce inflammation and oxidative stress. While animal studies show promise for conditions like Alzheimer's and Parkinson's, human clinical data is not provided here, so it should be viewed as a potential supportive supplement rather than a cure.

Metformin is a common pharmacological insulin sensitization therapy used to treat PCOS, though specific dosing protocols are not detailed in this review excerpt.

Metformin is a standard medication for treating insulin resistance in PCOS. Consult a doctor for appropriate dosing and monitoring.

Activation of the AMPK signaling pathway ameliorates fatty liver disease (FLD) by inhibiting lipid synthesis and promoting fatty acid oxidation.

Supporting liver health involves maintaining cellular energy balance. While specific dietary interventions are not detailed in this mechanism review, the activation of AMPK (often associated with energy deficit or exercise) is a key biological mechanism for reducing liver fat. Focus on metabolic health markers rather than just fat intake.

AMPK activation reduces liver fat accumulation by downregulating lipid synthesis genes (FAS, SREBP-1c, ACC, HMGCR) and upregulating fatty acid oxidation genes (CPT1, PGC1, HSL, ATGL).

Understanding the specific genes involved (like CPT1 for burning fat and FAS for making fat) helps explain why metabolic health is complex. Interventions that activate AMPK can shift this balance.

Ethanol consumption inhibits AMPK activity and reduces CPT1 expression, leading to fatty liver disease.

Chronic alcohol consumption disrupts the liver's ability to regulate fat metabolism by inhibiting AMPK. Reducing alcohol intake may help restore this regulatory pathway.

Serum Anti-Mullerian Hormone (AMH) can be used as an alternative to ultrasound for defining Polycystic Ovarian Morphology (PCOM) in adults, but should not be used as a single test or in adolescents.

In adults, AMH blood tests can help confirm PCOS if ultrasound isn't possible or preferred, but it is never used alone. It is not recommended for adolescents. Discuss with your doctor if it fits your diagnostic pathway.

Gut microbiota dysbiosis, specifically involving Escherichia Coli producing the CIpB protein, may contribute to eating disorder pathology by mimicking satiety hormones and triggering autoimmune reactions.

Current research suggests gut health may play a role in eating disorders, but it is not yet a primary treatment target. Focus on established treatments like nutritional rehabilitation and therapy. Future probiotics or microbiome-targeted therapies may emerge, but are not currently standard care.

Lipophagy, the selective autophagic degradation of lipid droplets, serves as a cytoprotective mechanism that prevents lipotoxicity and cell death (necrosis/apoptosis) by mobilizing fatty acids for energy production (ATP synthesis) and reducing toxic lipid accumulation.

Your body has a natural system (lipophagy) to break down stored fat for energy when needed. This process helps protect your cells from damage caused by excess fat. While you cannot directly 'dose' this molecular pathway, supporting metabolic health through regular physical activity and avoiding chronic overnutrition helps maintain the efficiency of your body's natural lipid management systems.

Elevated plasma branched-chain amino acid (BCAA) levels contribute to the development of insulin resistance through multiple mechanisms, including mTOR/S6K-mediated inhibition of insulin signaling, inhibition of pyruvate dehydrogenase (PDH), and accumulation of toxic metabolites causing mitochondrial dysfunction.

If you have insulin resistance or Type 2 Diabetes, be mindful of very high intakes of branched-chain amino acids (found in red meat, dairy, and supplements), especially when combined with high-fat meals, as this may worsen insulin sensitivity. Focus on balanced protein intake rather than extreme high-protein or high-fat combinations, and prioritize exercise which helps clear BCAA.

Pharmacological activation of the BCKD complex using agents like BT2 or Sodium Phenylbutyrate (NaPB) accelerates BCAA catabolism, lowers plasma BCAA levels, and improves insulin sensitivity in animal models of obesity and diabetes.

Current research shows that drugs like BT2 and NaPB can fix BCAA metabolism issues in lab animals, improving insulin sensitivity. However, these are not yet approved or proven safe for humans for this purpose. Focus on exercise and balanced nutrition to naturally support BCAA clearance.

Different forms of cell death (apoptosis, necroptosis, pyroptosis) in adipose tissue have distinct inflammatory consequences; necroptosis is highly inflammatory and linked to metabolic dysfunction, while apoptosis may trigger anti-inflammatory macrophage responses.

Not all fat loss is created equal. The way fat cells die matters. Necroptosis (inflammatory cell death) worsens metabolic health, while apoptosis might sometimes trigger a less inflammatory response. Strategies that minimize inflammatory cell death may be metabolically superior.